The Celiac Disease Foundation is pleased to invite you to the FDA’s GREAT VI, Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics Workshop on Celiac Disease, on Thursday, July 22, 2021 at 9AM Eastern.

The FDA has selected three of our Patient Advocates – Kelsey Smith and Beckett and Kathy Hardin – to share their patient and caregiver perspectives on celiac disease drug development and trial participation.

Show your support by listening in as the FDA discusses what is needed
to approve new celiac disease treatments.

Register Now

Kelsey Smith
iAdvocate Forum Moderator, Patient Education & Advocacy Summit Steering Committee, FDA Workshop Planning Committee & Panel Speaker

“I am excited to be a part of the upcoming FDA Workshop on celiac disease, and I hope it brings about more patient-centered conversations on the future of diagnosing and treating the disease. Hearing directly from patients about our lived experiences is critical to providing the FDA with better insight into the importance of the work of our researchers and scientists in developing treatments for our celiac disease symptoms and long-term health.”



Beckett and Kathy Hardin
Patient Advocates, FDA Workshop Panel Speakers

“We are so grateful to be participating in the FDA Workshop. As with so many similar families, we know firsthand how medications or other therapeutics would directly improve our family’s quality of life. Moreover, we appreciate that the FDA is interested in the lived experience of a child with celiac disease, considering more fully the importance of pediatric clinical trials as well as how to minimize any negative impacts on the children participating.

One of Beckett’s strongest elementary school memories was not being able to eat special, homemade St. Patrick’s Day cookies. To most adults, this would be only disappointing, but to Beckett it was another missed opportunity to be a regular fourth grader. These stories and their emotional impacts can only come from children, as their world views are unique from those of adults.”



For information on becoming a Patient Advocate, visit